Sam Chun Dang Pharm. Co., Ltd (000250.KQ)
KRW 114400.0
(-4.75%)
KRW 114400.0
(-4.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 192.66 Billion | 177.33 Billion | 167.27 Billion | 166.86 Billion | 186.6 Billion | 159.96 Billion |
| Cost of Revenue | 98.18 Billion | 89.42 Billion | 86.02 Billion | 74.32 Billion | 77.14 Billion | 77.32 Billion |
| Gross Profit | 94.48 Billion | 87.9 Billion | 81.24 Billion | 92.53 Billion | 109.46 Billion | 82.63 Billion |
| Operating Expenses | 84.83 Billion | 75.33 Billion | 96.53 Billion | 88.73 Billion | 85.65 Billion | 68.33 Billion |
| Selling, General and Administrative Expenses | 51.98 Billion | 68.73 Billion | 63.05 Billion | 66.06 Billion | 65.44 Billion | 57.33 Billion |
| Research and Development Expenses | 5.04 Billion | 5.47 Billion | 32.38 Billion | 21.18 Billion | 17.92 Billion | 8.95 Billion |
| Other Expenses | 30.37 Billion | -1.13 Billion | -1.08 Billion | -1.48 Billion | -2.28 Billion | -2.03 Billion |
| Cost and Expenses | 183.01 Billion | 164.76 Billion | 182.56 Billion | 163.05 Billion | 162.79 Billion | 145.65 Billion |
| Operating Income | 9.55 Billion | 12.56 Billion | -15.28 Billion | 3.8 Billion | 23.8 Billion | 14.3 Billion |
| Interest Expense | 2.57 Billion | 2.79 Billion | 1.89 Billion | 638.41 Million | 816.82 Million | 231.94 Million |
| Income Tax Expense | -271.03 Million | 87.7 Million | -9.18 Billion | 9.08 Billion | -282.44 Million | -131.52 Million |
| Earnings before Tax | -4.45 Billion | 8.91 Billion | -19.54 Billion | 16.58 Billion | 19.31 Billion | 14.46 Billion |
| Net Income | -10.38 Billion | 5.83 Billion | -16.55 Billion | -965.67 Million | 10.45 Billion | 8.75 Billion |
| Earnings Per Share Basic | -463.03 | 264.52 | -750.19 | -44.57 | 488.26 | 408.98 |
| Earnings Per Share Diluted | -456.23 | 264.52 | -750.19 | -44.57 | 486.59 | 408.98 |
| Weighted Average Shares Outstanding | 22.42 Million | 22.06 Million | 22.06 Million | 21.66 Million | 21.4 Million | 21.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.75 Million | 22.06 Million | 22.06 Million | 21.66 Million | 21.47 Million | 21.4 Million |
| Gross Margin | 0.49 | 0.50 | 0.49 | 0.55 | 0.59 | 0.52 |
| EBIT Margin | 0.03 | 0.11 | -0.05 | 0.06 | 0.16 | 0.13 |
| Profit Margin | -0.05 | 0.03 | -0.10 | -0.01 | 0.06 | 0.05 |
| EBITDA | 6.54 Billion | 19.36 Billion | -10.91 Billion | 23.9 Billion | 26.62 Billion | 20.99 Billion |
| Earnings Before Tax Margin | 0.05 | 0.07 | -0.09 | 0.02 | 0.13 | 0.09 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 54.88 Billion | 48.45 Billion | 52.49 Billion | 192.66 Billion | 48.44 Billion | 47.57 Billion |
| Cost of Revenue | 29.84 Billion | 25.08 Billion | 28.18 Billion | 98.18 Billion | 24.45 Billion | 23.6 Billion |
| Gross Profit | 25.04 Billion | 23.37 Billion | 24.31 Billion | 94.48 Billion | 23.98 Billion | 23.97 Billion |
| Operating Expenses | 22.9 Billion | 21.5 Billion | 22.22 Billion | 84.83 Billion | 21.6 Billion | 20.73 Billion |
| Selling, General and Administrative Expenses | 20.83 Billion | 19.64 Billion | 20.82 Billion | - | 19.78 Billion | 19.18 Billion |
| Research and Development Expenses | 1.84 Billion | 1.41 Billion | 1.13 Billion | - | 1.51 Billion | 1.34 Billion |
| Other Expenses | -224.12 Million | -455.85 Million | -266.58 Million | -1.05 Billion | -297.07 Million | -195.5 Million |
| Cost and Expenses | 52.75 Billion | 46.59 Billion | 50.4 Billion | 183.01 Billion | 46.05 Billion | 44.33 Billion |
| Operating Income | 2.13 Billion | 1.86 Billion | 2.08 Billion | 9.64 Billion | 2.38 Billion | 3.24 Billion |
| Interest Expense | - | 647.88 Million | 205.16 Million | 2.57 Billion | 931.61 Million | 314.13 Million |
| Income Tax Expense | 2.56 Billion | 484.02 Million | -2.2 Billion | -271.03 Million | 835.91 Million | 206.75 Million |
| Earnings before Tax | 4.39 Billion | 2.8 Billion | 4.7 Billion | -4.45 Billion | -9.5 Billion | -1.74 Billion |
| Net Income | 174.06 Million | 1.13 Billion | 4.9 Billion | -10.38 Billion | -11.81 Billion | -3.83 Billion |
| Earnings Per Share Basic | 7.64 | 50.08 | 215.65 | - | -535.30 | -173.72 |
| Earnings Per Share Diluted | 7.64 | 50.08 | 215.65 | - | -535.30 | -173.72 |
| Weighted Average Shares Outstanding | 22.77 Million | 22.75 Million | 22.75 Million | 22.42 Million | 22.06 Million | 22.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.77 Million | 22.75 Million | 22.75 Million | 22.42 Million | 22.06 Million | 22.06 Million |
| Gross Margin | 0.46 | 0.48 | 0.46 | 0.49 | 0.50 | 0.50 |
| EBIT Margin | 0.08 | 0.08 | 0.08 | - | 0.09 | 0.11 |
| Profit Margin | 0.00 | 0.02 | 0.09 | -0.05 | -0.24 | -0.08 |
| EBITDA | 4.43 Billion | 3.92 Billion | 4.16 Billion | - | 4.41 Billion | 5.39 Billion |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.07 |
ZENOTECH
MHUB
PANCHSHEEL
BWG
SHAMROIN
CCJ